These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 961209)

  • 1. [Occurrence of an increased reaction to challenge infection after vaccination with aerosols of inactivated foot-and-mouth disease virus].
    Bauer K; Neukirch M
    Zentralbl Veterinarmed B; 1976 Jun; 23(5-6):374-83. PubMed ID: 961209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intranasal vaccination of cattle against foot-and-mouth disease].
    Bauer K; Straub OC
    Berl Munch Tierarztl Wochenschr; 1985 Jul; 98(7):247-50. PubMed ID: 2994624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of formation of immunity in sheep vaccinated with different doses of foot-and-mouth disease vaccine from lapinized virus A22].
    Rakhmanin PP; Alekhin RM; Antoniuk VP; Darda PN; Kruglikov BA
    Veterinariia; 1977 Jan; (1):49-51. PubMed ID: 855170
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
    Hyslop NS; Morrow AW
    Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
    Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
    Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
    Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
    Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccines.
    Anderson EC; Masters RC; Mowat GN
    Res Vet Sci; 1971 Jul; 12(4):342-50. PubMed ID: 5558541
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease.
    Barnard AL; Arriens A; Cox S; Barnett P; Kristensen B; Summerfield A; McCullough KC
    Vaccine; 2005 Jan; 23(8):1037-47. PubMed ID: 15620477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant fusion protein and DNA vaccines against foot-and-mouth disease virus type Asia 1 infection in guinea pigs.
    Zhang Q; Zhu MW; Yang YQ; Shao M; Zhang ZY; Lan HY; Yan WY; Wu JJ; Zheng ZX
    Acta Virol; 2003; 47(4):237-43. PubMed ID: 15068379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.